logo
Share SHARE
FONT-SIZE Plus   Neg

Telik Says FDA Grants Orphan Drug Status To Telintra, Shares Soar - Quick Facts

Telik, Inc. (TELK) announced that its product candidate, ezatiostat HCL (Telintra), has been granted orphan drug designation by the US Food and Drug Administration for the treatment of myelodysplastic syndrome (MDS).

Orphan designation grants potential US market exclusivity to a drug for the treatment of a specified condition for a period of seven years following FDA marketing approval.

Telintra is a novel inhibitor of the enzyme glutathione S-transferase P1-1, leading to activation of Jun kinase, a key regulator of cellular growth and differentiation of blood precursor cells.

Telintra has been shown to cause clinically significant and sustained reduction in red blood cell transfusions, transfusion independence and multilineage responses in MDS patients. The results of four clinical trials of Telintra in MDS have been reported in peer-reviewed scientific journals.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Many apps are designed to enhance productivity, simplify social networking or provide other useful benefits. These apps are practical and functional. Others are shaping day-to-day lives. Thanks to these apps, the smartphones have already replaced the watch, calendar, calculator, address book, voice... The global app market would be worth $6.3 trillion by 2021, compared to $1.3 trillion in 2016, according to a new report from analyst firm App Annie. The expected growth in the global app market is said to reflect the significantly increasing number of smartphone owners and their use of mobile apps. Agricultural products giant Monsanto Co. on Wednesday reported a nearly 18 percent increase in profit for the third quarter from last year, reflecting strong sales growth in the agricultural productivity segment and a lower tax provision. Looking ahead, the company affirmed its outlook for fiscal 2017 ongoing earnings.
comments powered by Disqus
Follow RTT